Boulder, Colorado-based Enveda has raised a $55 million Series B extension to combine ancient remedies with AI for drug discovery. The funding round included investors such as Microsoft. Enveda aims to leverage centuries-old knowledge of natural remedies and modern artificial intelligence to develop new pharmaceuticals. For instance, people chewed willow tree bark for pain relief long before Bayer isolated its active ingredient.
Synthetic Intelligence Unlocks New Potentialities in Anti-Getting older Drugs Researchers have utilized AI to find... https://t.co/waYJ9AZlQH
Boulder, Colorado-based Enveda, which combines AI with ancient remedies for drug discovery, raised a $55M Series B extension from investors including Microsoft (@mtemkin / TechCrunch) https://t.co/76iQ7R3a4V 📫 Subscribe: https://t.co/OyWeKSRpIM https://t.co/6hWCeDKy00
Enveda raises $55M to combine ancient remedies with AI for drug discovery: https://t.co/jI4CAwK3R0 by TechCrunch #infosec #cybersecurity #technology #news
Enveda raises $55M to combine ancient remedies with AI for drug discovery: For centuries, people chewed willow tree bark to relieve pain, but scientists at chemical firm Bayer didn’t isolate its active ingredient until the 1800s and… https://t.co/Ks1Uq5kREz #AI #AInews #AItips
Enveda raises $55M to combine ancient remedies with AI for drug discovery https://t.co/fVsceXHVJR